Paid Clinical Trials in New Jersey

New Jersey has 1,726 paid clinical trials enrolling now across cities including New Brunswick, Middletown and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,560 clinical trials

Get a weekly email when new trials open in New Brunswick, NJ.

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

for Refractory Melanoma

Sites in Morristown +7 more locations

Sponsor: Diakonos Oncology Corporation

Sex: All·Age: 18+

Code: NCT07288112·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for Malignant Neoplasm

Drug: MK-4716

Sites in New Brunswick +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07247110·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation

for Obstructive Sleep Apnea

Sites in Summit +1 more location

Sponsor: Nyxoah Inc.

Sex: All·Age: 22+

Code: NCT07331285·Recruiting·Listed Jan 2026

Apply to this trial

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

for Bipolar I Disorder

Drug: NBI-1117568

Sites in Marlton +8 more locations

Sponsor: Neurocrine Biosciences

Sex: All·Age: 18 - 65

Code: NCT07288320·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

for Non-infectious Anterior Uveitis

Sites in Palisades Park +5 more locations

Sponsor: Novaliq GmbH

Sex: All·Age: 18+

Code: NCT07285070·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

for Osteomyelitis

Sites in Oradell +3 more locations

Sponsor: Biocomposites Ltd

Sex: All·Age: 18+

Code: NCT07270380·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

for Chronic Lymphocytic Leukemia

Drug: Emavusertib

Sites in Florham Park +5 more locations

Sponsor: Curis, Inc.

Sex: All·Age: 18+

Code: NCT07271667·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

for Patients With Chemotherapy-Induced Thrombocytopenia

Sites in Morristown +6 more locations

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Sex: All·Age: 18+

Code: NCT07286032·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

for Solid Tumors, Adult

Sites in East Brunswick +7 more locations

Sponsor: Hutchmed

Sex: All·Age: 18+

Code: NCT07228247·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for Transthyretin Amyloidosis With Cardiomyopathy

Sites in New Brunswick +3 more locations

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07358078·Recruiting·Listed Jan 2026

Apply to this trial

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

for Bladder Cancer

Sites in New Brunswick +3 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07222488·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Hackensack +9 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07140016·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

for Neoplasm Malignant

Drug: Calderasib

Sites in New Brunswick +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07209111·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

for Large Cell Neuroendocrine Carcinoma

Sites in Princeton +4 more locations

Sponsor: Molecular Partners AG

Sex: All·Age: 18+

Code: NCT07278479·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for Glioblastoma

Sites in Neptune City +6 more locations

Sponsor: GT Medical Technologies, Inc.

Sex: All·Age: 18+

Code: NCT07195591·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

for Breast Cancer

Sites in Princeton +3 more locations

Sponsor: Cellectar Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07311993·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

for Schizophrenia

Drug: KarXT

Sites in Marlton +7 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 55

Code: NCT07061288·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

for Alzheimer Disease

Sites in Toms River +5 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 50 - 85

Code: NCT06297590·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for Atrial Fibrillation

Sites in Camden +5 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07217067·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

COPD Exacerbation Follow Up

for COPD (Chronic Obstructive Pulmonary Disease)

Sites in Cherry Hill +4 more locations

Sponsor: Viz.ai, Inc.

Sex: All·Age: 40+

Code: NCT07118306·Recruiting·Listed Aug 2025

Apply to this trial

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

for Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Drug: Botensilimab

Sites in Morristown +5 more locations

Sponsor: Stingray Therapeutics

Sex: All·Age: 18+

Code: NCT06589440·Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for Esophageal Squamous Cell Carcinoma

Sites in Morristown +12 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06644781·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

for Catheter-Related Infections

Sites in Hackensack +5 more locations

Sponsor: CorMedix Therapeutics

Sex: All·Age: Up to 17

Code: NCT06714864·Phase 4·Recruiting·Listed Dec 2024

Apply to this trial

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for Congenital Adrenal Hyperplasia

Sites in New Brunswick +8 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 1 - 17

Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Morristown +7 more locations

Sponsor: Vaxiion Therapeutics

Sex: All·Age: 18+

Code: NCT05901285·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Leukemia, Myeloid, Acute

Sites in Hackensack +5 more locations

Sponsor: Orca Biosystems, Inc.

Sex: All·Age: 18+

Code: NCT07216443·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for Colorectal Cancer

Sites in New Brunswick +12 more locations

Sponsor: Criterium, Inc.

Sex: All·Age: 18+

Code: NCT06992258·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

Sites in Hackensack +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Elranatamab

Sites in Hackensack +3 more locations

Sponsor: Celgene

Sex: All·Age: 18+

Code: NCT06988488·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

for Bladder Cancer

Sites in New Brunswick +2 more locations

Sponsor: Photocure

Sex: All·Age: 18+

Code: NCT07144319·Recruiting·Listed Aug 2025

Apply to this trial

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

for Acute Myeloid Leukaemia (AML)

Sites in Morristown +7 more locations

Sponsor: Moleculin Biotech, Inc.

Sex: All·Age: 18 - 80

Code: NCT06788756·Phase 2, Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

for Nonmuscle-invasive Bladder Cancer

Sites in New Brunswick +8 more locations

Sponsor: ImmVira Pharma Co. Ltd

Sex: All·Age: 18+

Code: NCT06971614·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Visugromab in Cachexia International Trial

for Cancer-associated Cachexia

Sites in East Brunswick +9 more locations

Sponsor: CatalYm GmbH

Sex: All·Age: 18+

Code: NCT07112196·Phase 2, Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for Small Cell Lung Cancer

Drug: Gocatamig

Sites in Hackensack +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06780137·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

for Phenylketonurias

Sites in Morristown +4 more locations

Sponsor: NGGT INC.

Sex: All·Age: 18 - 55

Code: NCT06332807·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in New Brunswick +14 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Hackensack +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06598800·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

The HEARTFELT Study

for Heart Failure

Sites in Hackensack +1 more location

Sponsor: Heartfelt Technologies

Sex: All·Age: 22+

Code: NCT06222099·Recruiting·Listed Jan 2024

Apply to this trial

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

for Moderate Alzheimer Disease

Sites in Newark +5 more locations

Sponsor: NKGen Biotech, Inc.

Sex: All·Age: 40 - 85

Code: NCT06189963·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

for Friedreich Ataxia

Sites in Eatontown +5 more locations

Sponsor: Larimar Therapeutics, Inc.

Sex: All·Age: 2 - 60

Code: NCT06447025·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial